These stocks are usually going up or down because of brokers upgraded or downgraded .If you are looking to day trade, you might want to check out the following stocks. I usually throw these on my watch list and monitor with resistance & support levels.You can also check previous stocks to buy reports- Right Here.
eBay (EBAY), Priceline.com (PCLN), Groupon (GRPN), Royal (AHONY) , Adtran (ADTN), Vertex Pharma (VRTX), Acme Packet (APKT), Solta Medical (SLTM), Callon Petroleum (CPE), Avon Products (AVP), Synovis Life (SYNO) were upgraded or downgraded by analysts.
eBay (EBAY) coverage resumed with a Conviction Buy at Goldman.Goldman believes eBay is well positioned to benefit from the convergence of online commerce and payments. Target $40
Priceline.com (PCLN) coverage resumed with a Buy at Goldman Target $610.
Priceline.com (PCLN) coverage resumed with a Buy at Goldman Target $610.
Groupon (GRPN) initiated with a Buy at Goldman Target $29.
Royal (AHONY) Ahold upgraded to Buy from Hold at ING Group.
Adtran (ADTN) downgraded to Hold from Buy at Jefferies.Jefferies downgraded Adtran citing risks from the NSN Broadband Access assets acquisition. The firm lowered its price target for shares to $29.75 from $36.
Vertex Pharma (VRTX) upgraded to Outperform from Underperform at Credit Suisse.Credit Suisse upgraded Vertex based on valuation, lowered HCV franchise expectations, and 2012 pipeline catalysts. Price target lowered to $37 from $39.
Acme Packet (APKT) upgraded to Outperform from Market Perform at Morgan Keegan. Morgan Keegan upgraded Acme Packet citing its sales opportunities of new applications. Price target raised to $45 from $44.
Solta Medical (SLTM) initiated with a Market Perform at Morgan Keegan Target $3.50.
Callon Petroleum (CPE) initiated with a Buy at Canaccord Target $7.50.
Avon Products (AVP) upgraded to Outperform from Market Perform at BMO Capital. BMO Capital upgraded Avon citing news the company will conduct an external search for a new CEO. Price target raised to $25 from $21.
Synovis Life (SYNO) downgraded to Neutral from Buy at Roth Capital.Roth Capital downgraded Synovis Life citing the acquisition by Baxter.
Royal (AHONY) Ahold upgraded to Buy from Hold at ING Group.
Adtran (ADTN) downgraded to Hold from Buy at Jefferies.Jefferies downgraded Adtran citing risks from the NSN Broadband Access assets acquisition. The firm lowered its price target for shares to $29.75 from $36.
Vertex Pharma (VRTX) upgraded to Outperform from Underperform at Credit Suisse.Credit Suisse upgraded Vertex based on valuation, lowered HCV franchise expectations, and 2012 pipeline catalysts. Price target lowered to $37 from $39.
Acme Packet (APKT) upgraded to Outperform from Market Perform at Morgan Keegan. Morgan Keegan upgraded Acme Packet citing its sales opportunities of new applications. Price target raised to $45 from $44.
Solta Medical (SLTM) initiated with a Market Perform at Morgan Keegan Target $3.50.
Callon Petroleum (CPE) initiated with a Buy at Canaccord Target $7.50.
Avon Products (AVP) upgraded to Outperform from Market Perform at BMO Capital. BMO Capital upgraded Avon citing news the company will conduct an external search for a new CEO. Price target raised to $25 from $21.
Synovis Life (SYNO) downgraded to Neutral from Buy at Roth Capital.Roth Capital downgraded Synovis Life citing the acquisition by Baxter.
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
